211 related articles for article (PubMed ID: 37877107)
1. An Overview of Current Biomarkers, the Therapeutic Implications, and the Emerging Role of hERG1 Expression in Gastric Cancer: A Literature Review.
Abdullah Y
Cureus; 2023 Oct; 15(10):e47501. PubMed ID: 37877107
[TBL] [Abstract][Full Text] [Related]
2. The role of potassium channels in tumours of the gastrointestinal tract: a focus on the human ether-à-go-go related gene 1 channels.
Arcangeli A; Duranti C; Iorio J; Lastraioli E
J Physiol; 2023 May; 601(9):1597-1610. PubMed ID: 36215066
[TBL] [Abstract][Full Text] [Related]
3. Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas.
Menéndez ST; Rodrigo JP; Alvarez-Teijeiro S; Villaronga MÁ; Allonca E; Vallina A; Astudillo A; Barros F; Suárez C; García-Pedrero JM
Mod Pathol; 2012 Aug; 25(8):1069-78. PubMed ID: 22460808
[TBL] [Abstract][Full Text] [Related]
4. hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications.
Crociani O; Lastraioli E; Boni L; Pillozzi S; Romoli MR; D'Amico M; Stefanini M; Crescioli S; Masi A; Taddei A; Bencini L; Bernini M; Farsi M; Beghelli S; Scarpa A; Messerini L; Tomezzoli A; Vindigni C; Morgagni P; Saragoni L; Giommoni E; Gasperoni S; Di Costanzo F; Roviello F; De Manzoni G; Bechi P; Arcangeli A
Clin Cancer Res; 2014 Mar; 20(6):1502-12. PubMed ID: 24449824
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of hERG1 expression in gastric cancer.
Ding XW; Yang WB; Gao S; Wang W; Li Z; Hu WM; Li JJ; Luo HS
Dig Dis Sci; 2010 Apr; 55(4):1004-10. PubMed ID: 19495974
[TBL] [Abstract][Full Text] [Related]
6. The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples.
Lastraioli E; Romoli MR; Iorio J; Lottini T; Chiudinelli M; Bencivenga M; Vindigni C; Tomezzoli A; De Manzoni G; Compagnoni B; Manzi I; Messerini L; Saragoni L; Arcangeli A;
Onco Targets Ther; 2019; 12():9377-9384. PubMed ID: 31807018
[TBL] [Abstract][Full Text] [Related]
7. hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy.
Muratori L; Petroni G; Antonuzzo L; Boni L; Iorio J; Lastraioli E; Bartoli G; Messerini L; Di Costanzo F; Arcangeli A
Onco Targets Ther; 2016; 9():6325-6332. PubMed ID: 27789963
[TBL] [Abstract][Full Text] [Related]
8. hERG1 is involved in the pathophysiological process and inhibited by berberine in SKOV3 cells.
Zhi D; Zhou K; Yu D; Fan X; Zhang J; Li X; Dong M
Oncol Lett; 2019 Jun; 17(6):5653-5661. PubMed ID: 31186788
[TBL] [Abstract][Full Text] [Related]
9. hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers.
Lastraioli E; Lottini T; Bencini L; Bernini M; Arcangeli A
Biomed Res Int; 2015; 2015():896432. PubMed ID: 26339650
[TBL] [Abstract][Full Text] [Related]
10. Physical and functional interaction between integrins and hERG1 channels in cancer cells.
Pillozzi S; Arcangeli A
Adv Exp Med Biol; 2010; 674():55-67. PubMed ID: 20549940
[TBL] [Abstract][Full Text] [Related]
11. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
12. Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives.
Niclauss N; Gütgemann I; Dohmen J; Kalff JC; Lingohr P
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830815
[TBL] [Abstract][Full Text] [Related]
13. Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex.
Santini L; Duranti C; Palandri C; Giammarino L; Musumeci M; Carlucci L; Capitani C; Colasurdo R; Recchia F; Cerbai E; Coppini R; Arcangeli A
Front Pharmacol; 2023; 14():1237431. PubMed ID: 37767396
[No Abstract] [Full Text] [Related]
14. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.
Lastraioli E; Perrone G; Sette A; Fiore A; Crociani O; Manoli S; D'Amico M; Masselli M; Iorio J; Callea M; Borzomati D; Nappo G; Bartolozzi F; Santini D; Bencini L; Farsi M; Boni L; Di Costanzo F; Schwab A; Onetti Muda A; Coppola R; Arcangeli A
Br J Cancer; 2015 Mar; 112(6):1076-87. PubMed ID: 25719829
[TBL] [Abstract][Full Text] [Related]
15. miR-493 inhibits proliferation and invasion in pancreatic cancer cells and inversely regulated hERG1 expression.
Zhi D; Zhao X; Dong M; Yan C
Oncol Lett; 2017 Dec; 14(6):7398-7404. PubMed ID: 29344180
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of hERG1 in resected esophageal squamous cell carcinomas: a marker for poor prognosis.
Ding XW; Luo HS; Luo B; Xu DQ; Gao S
J Surg Oncol; 2008 Jan; 97(1):57-62. PubMed ID: 17786970
[TBL] [Abstract][Full Text] [Related]
17. Molecular-targeted first-line therapy for advanced gastric cancer.
Song H; Zhu J; Lu D
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011461. PubMed ID: 27432490
[TBL] [Abstract][Full Text] [Related]
18. herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells.
Lastraioli E; Guasti L; Crociani O; Polvani S; Hofmann G; Witchel H; Bencini L; Calistri M; Messerini L; Scatizzi M; Moretti R; Wanke E; Olivotto M; Mugnai G; Arcangeli A
Cancer Res; 2004 Jan; 64(2):606-11. PubMed ID: 14744775
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas.
Iorio J; Antonuzzo L; Scarpi E; D'Amico M; Duranti C; Messerini L; Sparano C; Caputo D; Lavacchi D; Borzomati D; Antonelli A; Nibid L; Perrone G; Coppola A; Coppola R; di Costanzo F; Lastraioli E; Arcangeli A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142530
[TBL] [Abstract][Full Text] [Related]
20. Long-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels.
Pier DM; Shehatou GS; Giblett S; Pullar CE; Trezise DJ; Pritchard CA; Challiss RA; Mitcheson JS
Mol Pharmacol; 2014 Aug; 86(2):211-21. PubMed ID: 24830940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
